Zewdu Woretaw S, Dagnew Samuel B, Zeleke Mulugeta M, Ferede Yared A, Kassie Achenef B, Moges Tilay A, Alemu Muluken A
Department of Pharmacology and Toxicology, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582251358929. doi: 10.1177/23259582251358929. Epub 2025 Jul 15.
ObjectiveAdverse drug reactions (ADRs) induce iatrogenic harm in antiretroviral therapy (ART) care continuum. However, there is a dearth of concrete evidence in a resource-limited setting. Thus, this study was designed to consolidate existing knowledge, thereby informing policy and clinical care to improve patient safety.DesignSystematic review and meta-analysis.Data sourcesPubMed, CINAHL, Web of Science, and EMBASE databases were searched.Eligibility criteriaEmploying the condition, context, and population framework, observational primary studies were included.Data extraction and synthesisIndependent reviewers undertook data extraction and synthesis. This meta-analysis employed the random-effects restricted maximum likelihood (REML) method, with its protocol preregistered on the International Register of Systematic Reviews (CRD42024546390).ResultsThe pooled prevalence of ADRs was 36.7% [95% CI: 26.6-46.9, = 99.64%].ConclusionAltogether, this study revealed that ART-related ADRs in Ethiopia was 36.7%, underscoring rigorous monitoring. Giving special emphasis to patients with female gender, advanced disease, comorbidities, malnutrition, TB treatment, and poor adherence is a prudent decision.
目的
药物不良反应(ADR)在抗逆转录病毒治疗(ART)的连续护理过程中会引发医源性伤害。然而,在资源有限的环境中,缺乏具体证据。因此,本研究旨在整合现有知识,从而为改善患者安全的政策和临床护理提供依据。
设计
系统评价和荟萃分析。
数据来源
检索了PubMed、CINAHL、科学网和EMBASE数据库。
纳入标准
采用疾病、背景和人群框架,纳入观察性原发性研究。
数据提取与合成
独立评审员进行数据提取与合成。本荟萃分析采用随机效应限制最大似然法(REML),其方案已在国际系统评价注册库(CRD42024546390)上预先注册。
结果
ADR的合并患病率为36.7%[95%CI:26.6-46.9,I² = 99.64%]。
结论
总之,本研究表明埃塞俄比亚与ART相关的ADR为36.7%,强调了严格监测的重要性。特别关注女性、疾病晚期、合并症、营养不良、结核病治疗和依从性差的患者是一项审慎的决定。